Neuroprotective Mechanisms of Resveratrol in Alzheimer’s Disease: Role of SIRT1
Open accessThe DOI matches its Crossref record; 169 of the 170 references it cites were found in a registry or an index.
Abstract
Alzheimer’s disease (AD) is a progressive and neurodegenerative disorder of the cortex and hippocampus, which eventually leads to cognitive impairment. Although the etiology of AD remains unclear, the presence of β ‐amyloid (A β ) peptides in these learning and memory regions is a hallmark of AD. Therefore, the inhibition of A β peptide aggregation has been considered the primary therapeutic strategy for AD treatment. Many studies have shown that resveratrol has antioxidant, anti‐inflammatory, and neuroprotective properties and can decrease the toxicity and aggregation of A β peptides in the hippocampus of AD patients, promote neurogenesis, and prevent hippocampal damage. In addition, the antioxidant activity of resveratrol plays an important role in neuronal differentiation through the activation of silent information regulator‐1 (SIRT1). SIRT1 plays a vital role in the growth and differentiation of neurons and prevents the apoptotic death of these neurons by deacetylating and repressing p53 activity; however, the exact mechanisms remain unclear. Resveratrol also has anti‐inflammatory effects as it suppresses M1 microglia activation, which is involved in the initiation of neurodegeneration, and promotes Th2 responses by increasing anti‐inflammatory cytokines and SIRT1 expression. This review will focus on the antioxidant and anti‐inflammatory neuroprotective effects of resveratrol, specifically on its role in SIRT1 and the association with AD pathophysiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Main cellular routes proposed for the mechanisms of resveratrol in Alzheimer's disease. Modified from Ma et al. [72].](https://figures.cochat.ai/paper-figures/298b13e31ae74366bf246f40fc9ced35/neuroprotective-mechanisms-of-resveratrol-in-alzheimers-disease-role-of-sirt1-figure-2.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Likewise, SIRT1 inhibits Aβ production and neuroinflammation and prevents neuronal apoptosis in AD models.414”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [414]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED: SIRT1 Suppresses β-Amyloid Production by Activating the α-Secretase Gene ADAM10
Donmez, G., Wang, D., Cohen, D. E., & Guarente, L. (2010) · Cell · doi:10.1016/j.cell.2010.06.020 · Cited by 432
RetractedMarwarha, G., Raza, S., Meiers, C., & Ghribi, O. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.015 · Cited by 107
RetractedSmall molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796 · cited 1×
“Some studies have reported that resveratrol is an activator of SIRT1 [27, 69], although further evidence shows that resveratrol is not a direct activator of SIRT1 [70], and that its role may be related to the activation of substrates of SIRT1 [71].”
BackgroundAMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300 · cited 7×
“Some neurodegenerative diseases, such as AD, are associated with oxidative stress and neuroinflammation, and proteins that are closely related to this neurological disorder (i.e., AMPK, SIRT1, and PGC-1α) can be modulated by resveratrol [152]; however, there are few clinical studies on resveratrol in AD patients.”
BackgroundInfluentialModulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750 · cited 1×
“vation and had strong neuroprotective effects [68, 155].”
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885 · cited 1×
“However, oxidative stress is also an important event in the pathogenesis of AD [89], as the generation and accumulation of ROS and reactive nitrogen species can accelerate fibrillization, increase the toxicity of Aβ, and promote neuronal death and neurodegeneration [90–93].”
BackgroundHIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., & Walle, U. K. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000885 · Cited by 1,880
Price, N. L., Gomes, A. P., Ling, A. J. Y., Duarte, F. V., Martin-Montalvo, A., North, B. J., Agarwal, B., Ye, L., Ramadori, G., Teodoro, J. S., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.003 · Cited by 1,602 · cited 1×
“Thus, showing a dose-dependent effect, resveratrol was able to activate AMPK independently of SIRT1 [116].”
BackgroundResveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases
Park, S.-J., Ahmad, F., Philp, A., Baar, K., Williams, T., Luo, H., Ke, H., Rehmann, H., Taussig, R., Brown, A. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.017 · Cited by 1,349
Liu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095
Kim, D., Nguyen, M. D., Dobbin, M. M., Fischer, A., Sananbenesi, F., Rodgers, J. T., Delalle, I., Baur, J. A., Sui, G., Armour, S. M., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601758 · Cited by 1,074 · cited 2×
“In this sense, resveratrol could indirectly activate SIRT1 expression [16] and lead to neuroprotection in AD cases [17].”
BackgroundNeurogenesis in the adult hippocampus
Kempermann, G., Song, H., & Gage, F. H. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a018812 · Cited by 1,072
Alzheimer's disease: strategies for disease modification
Citron, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2896 · Cited by 1,064
Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice
Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., Klose, J., & Shen, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401135200 · Cited by 995
Plant Foods and Herbal Sources of Resveratrol
Burns, J., Yokota, T., Ashihara, H., Lean, M. E. J., & Crozier, A. (2002) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0112973 · Cited by 993
A novel pathway regulates memory and plasticity via SIRT1 and miR-134
Gao, J., Wang, W.-Y., Mao, Y.-W., Gräff, J., Guan, J.-S., Pan, L., Mak, G., Kim, D., Su, S. C., & Tsai, L.-H. (2010) · Nature · doi:10.1038/nature09271 · Cited by 975 · cited 1×
“In the adult brain, SIRT1 was shown to be essential for synaptic plasticity, cognitive functions [100], and the modulation of learning and memory function [101].”
BackgroundSRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1
Pacholec, M., Bleasdale, J. E., Chrunyk, B., Cunningham, D., Flynn, D., Garofalo, R. S., Griffith, D., Griffor, M., Loulakis, P., Pabst, B., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.088682 · Cited by 915 · cited 1×
“Some studies have reported that resveratrol is an activator of SIRT1 [27, 69], although further evidence shows that resveratrol is not a direct activator of SIRT1 [70], and that its role may be related to the activation of substrates of SIRT1 [71].”
BackgroundAntioxidant properties of resveratrol: A structure–activity insight
Gülçin, İ. (2010) · Innovative Food Science & Emerging Technologies · doi:10.1016/j.ifset.2009.07.002 · Cited by 894
Resveratrol Promotes Clearance of Alzheimer's Disease Amyloid-β Peptides
Marambaud, P., Zhao, H., & Davies, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508246200 · Cited by 749
Substrate-specific activation of sirtuins by resveratrol
Kaeberlein, M., McDonagh, T., Heltweg, B., Hixon, J., Westman, E. A., Caldwell, S. D., Napper, A., Curtis, R., DiStefano, P. S., Fields, S., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500655200 · Cited by 745
SIRT1 Protects against Microglia-dependent Amyloid-β Toxicity through Inhibiting NF-κB Signaling
Chen, J., Zhou, Y., Mueller-Steiner, S., Chen, L.-F., Kwon, H., Yi, S., Mucke, L., & Gan, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509329200 · Cited by 740 · cited 4×
“Activation of SIRT1 by resveratrol prevents Aβ-induced microglial death and contributes to improved cognitive function [32].”
BackgroundInfluentialGambini, J., Inglés, M., Olaso, G., Lopez-Grueso, R., Bonet-Costa, V., Gimeno-Mallench, L., Mas-Bargues, C., Abdelaziz, K. M., Gomez-Cabrera, M. C., Vina, J., et al. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/837042 · Cited by 737
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
Turner, R. S., Thomas, R. G., Craft, S., van Dyck, C. H., Mintzer, J., Reynolds, B. A., Brewer, J. B., Rissman, R. A., Raman, R., Aisen, P. S., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000002035 · Cited by 736
Resveratrol stimulates AMP kinase activity in neurons
Dasgupta, B., & Milbrandt, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610068104 · Cited by 723 · cited 1×
“Nevertheless, Dasgupta andMilbrandt show that resveratrol is a potent activator of AMP-activated protein kinase (AMPK) function, and resveratrol-mediated AMPK activation was independent of SIRT1 [114].”
BackgroundResveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease
Moussa, C., Hebron, M., Huang, X., Ahn, J., Rissman, R. A., Aisen, P. S., & Turner, R. S. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0779-0 · Cited by 705
Memory loss in Alzheimer's disease
Jahn, H. (2013) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2013.15.4/hjahn · Cited by 653 · cited 1×
“Alzheimer’s disease (AD) is a neurodegenerative pathology that causes impaired cognitive functioning and memory [1, 2].”
BackgroundVingtdeux, V., Giliberto, L., Zhao, H., Chandakkar, P., Wu, Q., Simon, J. E., Janle, E. M., Lobo, J., Ferruzzi, M. G., Davies, P., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.060061 · Cited by 645
Resveratrol bioavailability and toxicity in humans
Cottart, C., Nivet‐Antoine, V., Laguillier‐Morizot, C., & Beaudeux, J. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900437 · Cited by 592
Barger, J. L., Kayo, T., Vann, J. M., Arias, E. B., Wang, J., Hacker, T. A., Wang, Y., Raederstorff, D., Morrow, J. D., Leeuwenburgh, C., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002264 · Cited by 580 · cited 1×
“Similarly, resveratrol also induced an increase of SIRT1 in a mice model [129].”
BackgroundSIRT1 Is Essential for Normal Cognitive Function and Synaptic Plasticity
Michan, S., Li, Y., Chou, M. M.-H., Parrella, E., Ge, H., Long, J. M., Allard, J. S., Lewis, K., Miller, M., Xu, W., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0027-10.2010 · Cited by 541 · cited 2×
“The absence of SIRT1 expression in hippocampal neurons is correlated with impaired cognitive abilities, including immediate memory, classical conditioning, and spatial learning [100].”
BackgroundMedicinal Natural Products: A Biosynthetic Approach
Dewick, P. M. (2001) · Wiley eBooks · doi:10.1002/0470846275 · Cited by 541
González-Reyes, R. E., Nava-Mesa, M. O., Vargas-Sánchez, K., Ariza-Salamanca, D., & Mora-Muñoz, L. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00427 · Cited by 527
Sparvoli, F., Martin, C., Scienza, A., Gavazzi, G., & Tonelli, C. (1994) · Plant Molecular Biology · doi:10.1007/bf00029856 · Cited by 498
SIRT1 in Neurodevelopment and Brain Senescence
Herskovits, A. Z., & Guarente, L. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.028 · Cited by 488
Karuppagounder, S. S., Pinto, J. T., Xu, H., Chen, H.-L., Beal, M. F., & Gibson, G. E. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2008.10.008 · Cited by 485
Sirtuin 1 Reduction Parallels the Accumulation of Tau in Alzheimer Disease
Julien, C., Tremblay, C., Émond, V., Lebbadi, M., Salem, N., Bennett, D. A., & Calon, F. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181922348 · Cited by 468
Calorie restriction and sirtuins revisited
Guarente, L. (2013) · Genes & Development · doi:10.1101/gad.227439.113 · Cited by 464
Crosstalk between Oxidative Stress and SIRT1: Impact on the Aging Process
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14023834 · Cited by 452
Capiralla, H., Vingtdeux, V., Zhao, H., Sankowski, R., Al‐Abed, Y., Davies, P., & Marambaud, P. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07594.x · Cited by 426
Resveratrol is not a direct activator of SIRT1 enzyme activity
Beher, D., Wu, J., Cumine, S., Kim, K. W., Lu, S., Atangan, L., & Wang, M. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00901.x · Cited by 426 · cited 1×
“In this sense, resveratrol could indirectly activate SIRT1 expression [16] and lead to neuroprotection in AD cases [17].”
BackgroundAlmeida, L., Vaz‐da‐Silva, M., Falcão, A., Soares, E., Costa, R., Loureiro, A. I., Fernandes‐Lopes, C., Rocha, J., Nunes, T., Wright, L., et al. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200800177 · Cited by 426
Yang, X., Xu, S., Qian, Y., & Xiao, Q. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.03.003 · Cited by 413
Neuroprotective action of resveratrol
Bastianetto, S., Ménard, C., & Quirion, R. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.09.011 · Cited by 407
Natural stilbenoids: distribution in the plant kingdom and chemotaxonomic interest in Vitaceae
Rivière, C., Pawlus, A. D., & Mérillon, J.-M. (2012) · Natural Product Reports · doi:10.1039/c2np20049j · Cited by 407
Neuroprotective strategies involving ROS in Alzheimer disease
Dumont, M., & Beal, M. F. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.026 · Cited by 402
Reddy, P. H., Tripathi, R., Troung, Q., Tirumala, K., Reddy, T. P., Anekonda, V., Shirendeb, U. P., Calkins, M. J., Reddy, A. P., Mao, P., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.011 · Cited by 394 · cited 1×
“The neuroinflammatory response via microglial activation and acetylcholine deficits are also considered to play significant roles in the pathophysiology of AD [83, 84].”
BackgroundAntioxidant Therapies for Alzheimer's Disease
Feng, Y., & Wang, X. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/472932 · Cited by 379
Effect of resveratrol and pterostilbene on aging and longevity
Li, Y., Li, S., & Lin, C. (2018) · BioFactors · doi:10.1002/biof.1400 · Cited by 346
Spanier, G., Xu, H., Xia, N., Tobias, S., Deng, S., Wojnowski, L., Förstermann, U., & Li, H. (2009) · PubMed · Cited by 339
Resveratrol—A boon for treating Alzheimer's disease?
Anekonda, T. S. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.04.004 · Cited by 339
Davidov-Pardo, G., & McClements, D. J. (2014) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2014.05.003 · Cited by 337
Resveratrol as a Therapeutic Agent for Neurodegenerative Diseases
Sun, A. Y., Wang, Q., Simonyi, A., & Sun, G. Y. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8111-y · Cited by 329
Alzheimer's Disease and Mild Cognitive Impairment
Kelley, B. J., & Petersen, R. C. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.03.008 · Cited by 326
The pharmacology of resveratrol in animals and humans
Park, E.-J., & Pezzuto, J. M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.01.014 · Cited by 302 · cited 1×
“Animal models also indicate that resveratrol improves the spatial memory by decreasing the accumulation of Aβ peptides and lipid peroxidation in the hippocampus, thus protecting against neuronal apoptosis [159].”
BackgroundThe Daily Oral Administration of High Doses of trans-Resveratrol to Rats for 28 Days Is Not Harmful
Juan, M. E., Vinardell, M. P., & Planas, J. M. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.2.257 · Cited by 293
Zhang, F., Liu, J., & Shi, J.-S. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.03.043 · Cited by 264
Albani, D., Polito, L., Batelli, S., De Mauro, S., Fracasso, C., Martelli, G., Colombo, L., Manzoni, C., Salmona, M., Caccia, S., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06228.x · Cited by 260
Resveratrol Is Absorbed in the Small Intestine as Resveratrol Glucuronide
Kuhnle, G., Spencer, J. P. E., Chowrimootoo, G., Schroeter, H., Debnam, E. S., Srai, S. K. S., Rice-Evans, C., & Hahn, U. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2750 · Cited by 249
Neuroprotective effects of resveratrol in Alzheimer disease pathology
Rege, S. D., Geetha, T., Griffin, G. D., Broderick, T. L., & Babu, J. R. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00218 · Cited by 243
Tabner, B. J., El-Agnaf, O. M. A., Turnbull, S., German, M. J., Paleologou, K. E., Hayashi, Y., Cooper, L. J., Fullwood, N. J., & Allsop, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500238200 · Cited by 242
Pasinetti, G. M., Wang, J., Ho, L., Zhao, W., & Dubner, L. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.10.006 · Cited by 239
Resveratrol, A Neuroprotective Supplement for Alzheimer's Disease
Li, F., Gong, Q., Dong, H., & Shi, J. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212798919075 · Cited by 230
Effects of Resveratrol and SIRT1 on PGC-1α Activity and Mitochondrial Biogenesis: A Reevaluation
Higashida, K., Kim, S. H., Jung, S. R., Asaka, M., Holloszy, J. O., & Han, D.-H. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001603 · Cited by 228
Lu, C., Guo, Y., Yan, J., Luo, Z., Luo, H.-B., Yan, M., Huang, L., & Li, X. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400567s · Cited by 226
SCHRÖDER, G., BROWN, J. W. S., & SCHRÖDER, J. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb13868.x · Cited by 220
Huang, T.-C., Lu, K.-T., Wo, Y.-Y. P., Wu, Y.-J., & Yang, Y.-L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029102 · Cited by 217
Multiplicity of effects and health benefits of resveratrol
Kuršvietienė, L., Stanevičienė, I., Mongirdienė, A., & Bernatonienė, J. (2016) · Medicina · doi:10.1016/j.medici.2016.03.003 · Cited by 216
Kaur, C., Rathnasamy, G., & Ling, E.-A. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9347-2 · Cited by 211
Wang, H., Jiang, T., Li, W., Gao, N., & Zhang, T. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2017.10.021 · Cited by 210
Bioavailability and safety study of resveratrol 500 mg tablets in healthy male and female volunteers
SERGIDES, C., CHIRILĂ, M., SILVESTRO, L., PITTA, D., & PITTAS, A. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2895 · Cited by 209
Resveratrol Improves Motoneuron Function and Extends Survival in SOD1G93A ALS Mice
Mancuso, R., del Valle, J., Modol, L., Martinez, A., Granado-Serrano, A. B., Ramirez-Núñez, O., Pallás, M., Portero-Otin, M., Osta, R., & Navarro, X. (2014) · Neurotherapeutics · doi:10.1007/s13311-013-0253-y · Cited by 206
Antioxidant Effects of Resveratrol in Cardiovascular, Cerebral and Metabolic Diseases
Carrizzo, A., Forte, M., Damato, A., Trimarco, V., Salzano, F., Bartolo, M., Maciag, A., Puca, A. A., & Vecchione, C. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.07.021 · Cited by 203
Resveratrol differentially modulates inflammatory responses of microglia and astrocytes
Lu, X., Ma, L., Ruan, L., Kong, Y., Mou, H., Zhang, Z., Wang, Z., Wang, J. M., & Le, Y. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-46 · Cited by 180
Resveratrol improves learning and memory in normally aged mice through microRNA-CREB pathway
Zhao, Y.-N., Li, W.-F., Li, F., Zhang, Z., Dai, Y.-D., Xu, A.-L., Qi, C., Gao, J.-M., & Gao, J. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.05.025 · Cited by 176
Venigalla, M., Sonego, S., Gyengesi, E., Sharman, M. J., & Münch, G. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2015.10.011 · Cited by 175
(2003) · Signal Transduction · doi:10.1002/sita.200390006 · Cited by 175
Frozza, R. L., Bernardi, A., Paese, K., Hoppe, J. B., Silva, T. D., Battastini, A. M. O., Pohlmann, A. R., Guterres, S. S., & Salbego, C. (2010) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2010.1161 · Cited by 172
Resveratrol: A Focus on Several Neurodegenerative Diseases
Tellone, E., Galtieri, A., Russo, A., Giardina, B., & Ficarra, S. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/392169 · Cited by 171
Neuroinflammation and anti-inflammatory therapy for Alzheimer’s disease
Moore, A. H., & O’Banion, M. K. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00162-x · Cited by 171
Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway
Zhang, Y., Chen, M., Zhou, Y., Yi, L., Gao, Y., Ran, L., Chen, S., Zhang, T., Zhou, X., Zou, D., et al. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500016 · Cited by 170 · cited 1×
“Resveratrol has numerous functions in neuroinflammation, as it induces mitophagy [143, 144].”
BackgroundFrozza, R. L., Bernardi, A., Hoppe, J. B., Meneghetti, A. B., Matté, A., Battastini, A. M. O., Pohlmann, A. R., Guterres, S. S., & Salbego, C. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8401-2 · Cited by 165 · cited 1×
“[61, 66] demonstrated that resveratrol nanoparticles reached the brain at higher concentrations than free resveratrol, resulting in increased bioavailability and possible neuroprotective effects.”
BackgroundKoo, J., Kang, E., Oh, Y.-S., Yang, D.-S., & Cho, J. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.11.014 · Cited by 165
Ramis, M. R., Esteban, S., Miralles, A., Tan, D.-X., & Reiter, R. J. (2015) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2015.03.008 · Cited by 164
Biscaro, B., Lindvall, O., Tesco, G., Ekdahl, C. T., & Nitsch, R. M. (2012) · Neurodegenerative Diseases · doi:10.1159/000330363 · Cited by 164
Sirtuin1: A Promising Serum Protein Marker for Early Detection of Alzheimer’s Disease
Kumar, R., Chaterjee, P., Sharma, P. K., Singh, A. K., Gupta, A., Gill, K., Tripathi, M., Dey, A. B., & Dey, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061560 · Cited by 162
Human Serum Albumin Can Regulate Amyloid-β Peptide Fiber Growth in the Brain Interstitium
Stanyon, H. F., & Viles, J. H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.c112.360800 · Cited by 162
Composition, bioactive compounds and antioxidant activity of common Indian fruits and vegetables
Singh, J. P., Kaur, A., Shevkani, K., & Singh, N. (2016) · Journal of Food Science and Technology · doi:10.1007/s13197-016-2412-8 · Cited by 157
Lofrumento, D. D., Nicolardi, G., Cianciulli, A., Nuccio, F. D., Pesa, V. L., Carofiglio, V., Dragone, T., Calvello, R., & Panaro, M. A. (2014) · Innate Immunity · doi:10.1177/1753425913488429 · Cited by 156
Inhibition of cholinesterase and amyloid‐β aggregation by resveratrol oligomers from Vitis amurensis
Jang, M. H., Piao, X. L., Kim, J. M., Kwon, S. W., & Park, J. H. (2008) · Phytotherapy Research · doi:10.1002/ptr.2406 · Cited by 153
Resveratrol Role in Autoimmune Disease—A Mini-Review
Oliveira, A., Monteiro, V., Navegantes-Lima, K., Reis, J., Gomes, R., Rodrigues, D., Gaspar, S., & Monteiro, M. (2017) · Nutrients · doi:10.3390/nu9121306 · Cited by 144
Self-citationA critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease
Reddy, P. H., Tonk, S., Kumar, S., Vijayan, M., Kandimalla, R., Kuruva, C. S., & Reddy, A. P. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.067 · Cited by 143
Resveratrol as a Therapeutic Agent for Alzheimer’s Disease
Ma, T., Tan, M.-S., Yu, J.-T., & Tan, L. (2014) · BioMed Research International · doi:10.1155/2014/350516 · Cited by 140
Zhao, H., Li, N., Wang, Q.-N., Cheng, X., Li, X. M., & Liu, T. T. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.10.006 · Cited by 138
Proteases and Glioma Angiogenesis
Lakka, S. S., Gondi, C. S., & Rao, J. S. (2005) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00118.x · Cited by 131
Antioxidant Treatment in Alzheimer's Disease: Current State
Gilgun‐Sherki, Y., Melamed, E., & Offen, D. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:21:1:1 · Cited by 131
Nimmagadda, V. K., Bever, C. T., Vattikunta, N. R., Talat, S., Ahmad, V., Nagalla, N. K., Trisler, D., Judge, S. I. V., Royal, W., Chandrasekaran, K., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202584 · Cited by 128
Negative Regulation of STAT3 Protein-mediated Cellular Respiration by SIRT1 Protein
Bernier, M., Paul, R. K., Martin-Montalvo, A., Scheibye-Knudsen, M., Song, S., He, H.-J., Armour, S. M., Hubbard, B. P., Bohr, V. A., Wang, L., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.200311 · Cited by 127
Bonoiu, A. C., Mahajan, S. D., Ye, L., Kumar, R., Ding, H. Y., Yong, K., Roy, I., Aalinkeel, R., Nair, B. B., Reynolds, J. L., et al. (2009) · Brain Research · doi:10.1016/j.brainres.2009.05.047 · Cited by 126
Li, S., Wang, X., & Kong, L. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.10.068 · Cited by 122
Chiang, M., Nicol, C. J. B., & Cheng, Y. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.10.002 · Cited by 120
Stilbene and Chalcone Synthases: Related Enzymes with Key Functions in Plant-Specific Pathways
Schröder, G., & Schröder, G. (1990) · Zeitschrift für Naturforschung C · doi:10.1515/znc-1990-1-202 · Cited by 118
Resveratrol ameliorates spatial learning memory impairment induced by Aβ 1–42 in rats
Wang, R., Zhang, Y., Li, J., & Zhang, C. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.08.051 · Cited by 117
Wu, J., Li, X., Zhu, G., Zhang, Y., He, M. Y., & Zhang, J. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.01.014 · Cited by 115
Resveratrol promotes hUC-MSCs engraftment and neural repair in a mouse model of Alzheimer’s disease
Wang, X., Ma, S., Yang, B., Huang, T., Meng, N., Xu, L., Xing, Q., Zhang, Y., Zhang, K., Li, Q., et al. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.10.032 · Cited by 112
Resveratrol serves as a protein-substrate interaction stabilizer in human SIRT1 activation
Hou, X., Rooklin, D., Fang, H., & Zhang, Y. (2016) · Scientific Reports · doi:10.1038/srep38186 · Cited by 111
Stilbenes from Vitis vinifera L. Waste: A Sustainable Tool for Controlling Plasmopara Viticola
Gabaston, J., Cantos-Villar, E., Biais, B., Waffo-Teguo, P., Renouf, E., Corio-Costet, M.-F., Richard, T., & Mérillon, J.-M. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b00241 · Cited by 111
The binding of resveratrol to monomer and fibril amyloid beta
Ge, J., Qiao, J., Qi, C., Wang, C.-W., & Zhou, J. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.08.012 · Cited by 109
Protective effects of resveratrol on aging-induced cognitive impairment in rats
Göçmez, S. S., Gacar, N., Utkan, T., Gacar, G., Scarpace, P. J., & Tümer, N. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.03.022 · Cited by 109
The Interrelation between Reactive Oxygen Species and Autophagy in Neurological Disorders
Fang, C., Gu, L., Smerin, D., Mao, S., & Xiong, X. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/8495160 · Cited by 109
Wang, J., Fivecoat, H. C., Ho, L., Pan, Y., Ling, E., & Pasinetti, G. M. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.11.015 · Cited by 105
The Development of New Therapeutics for Alzheimer's Disease
Carter, M. D., Simms, G. A., & Weaver, D. F. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.165 · Cited by 105
Resveratrol and Amyloid-Beta: Mechanistic Insights
Jia, Y., Wang, N., & Liu, X. (2017) · Nutrients · doi:10.3390/nu9101122 · Cited by 102
Deng, H., & Mi, M. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1950-9 · Cited by 101
Mansur, A. D. P., Roggério, A., Góes, M. F. S., Avakian, S. D., Leal, D. P., Maranhão, R. C., & Strunz, C. M. C. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.10.058 · Cited by 98
Imamura, H., Yamaguchi, T., Nagayama, D., Saiki, A., Shirai, K., & Tatsuno, I. (2017) · International Heart Journal · doi:10.1536/ihj.16-373 · Cited by 98
Pasinetti, G. M., Wang, J., Marambaud, P., Ferruzzi, M., Gregor, P., Knable, L. A., & Ho, L. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.08.014 · Cited by 97
Bruisson, S., Maillot-Vernier, P., Schellenbaum, P., Walter, B., Gindro, K., & Deglène-Benbrahim, L. (2016) · Phytochemistry · doi:10.1016/j.phytochem.2016.09.002 · Cited by 97
The association between PGC-1α and Alzheimer's disease
Sweeney, G., & Song, J. (2016) · Anatomy & Cell Biology · doi:10.5115/acb.2016.49.1.1 · Cited by 93 · cited 2×
“SIRT1 can also increase PGC-1α activity, which leads to the inhibition of Aβ production and improved mitochondrial dysfunction [19].”
BackgroundTlili, N., Feriani, A., Saadoui, E., Nasri, N., & Khaldi, A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.12.052 · Cited by 93
Shen, C., Cheng, W. N., Yu, P., Wang, L., Zhou, L., Zeng, L., & Yang, Q. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5670 · Cited by 92
Resveratrol induces dephosphorylation of Tau by interfering with the MID1-PP2A complex
Schweiger, S., Matthes, F., Posey, K., Kickstein, E., Weber, S., Hettich, M. M., Pfurtscheller, S., Ehninger, D., Schneider, R., & Krauß, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-12974-4 · Cited by 89
Quincozes‐Santos, A., Bobermin, L. D., Tramontina, A. C., Wartchow, K. M., Tagliari, B., Souza, D. O., Wyse, Â. T. D. S., & Gonçalves, C. (2014) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.12.021 · Cited by 88
Xia, Y., Qiang, X., Li, Y., Luo, L., Xu, R., Zheng, Y., Cao, Z., Tan, Z., & Deng, Y. (2017) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2017.02.016 · Cited by 86
Simão, F., Matté, A., Pagnussat, A. S., Netto, C. A., & Salbego, C. G. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.06.009 · Cited by 80
Moriya, J., Chen, R., Yamakawa, J.-I., Sasaki, K., Ishigaki, Y., & Takahashi, T. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.354 · Cited by 78
Curcuminoids and resveratrol as anti-Alzheimer agents
Villaflores, O. B., Chen, Y.-J., Chen, C.-P., Yeh, J.-M., & Wu, T.-Y. (2012) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2012.09.005 · Cited by 77
The role of sirtuins in Alzheimer's disease
Lalla, R., & Donmez, G. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00016 · Cited by 72
Sadı, G., & Konat, D. (2015) · Pharmaceutical Biology · doi:10.3109/13880209.2015.1056311 · Cited by 71
Nutraceuticals: An emerging therapeutic approach against the pathogenesis of Alzheimer’s disease
Sadhukhan, P., Saha, S., Dutta, S., Mahalanobish, S., & Sil, P. C. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.11.028 · Cited by 70
Rege, S., Geetha, T., Broderick, T., & Babu, J. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150204130009 · Cited by 68
Resveratrol derivatives as a pharmacological tool
Biasutto, L., Mattarei, A., Azzolini, M., Spina, M. L., Nicola Sassi, A., Romio, M., Paradisi, C., & Zoratti, M. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13401 · Cited by 68
Morris-Blanco, K. C., Cohan, C. H., Neumann, J. T., Sick, T. J., & Pérez‐Pinzón, M. A. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.51 · Cited by 67
(1995) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7337-6 · Cited by 65
SIRT1 negatively regulates amyloid-beta-induced inflammation via the NF-κB pathway
Cao, L., Liu, C., Wang, F., & Wang, H. (2013) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20132903 · Cited by 62
Albuquerque, R. F. V., Malcher, N. S., Amado, L. L., Coleman, M. D., dos Santos, D. C., Borges, R. S., Valente, S. A. D. S., Valente, V. D. C., & Monteiro, M. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134768 · Cited by 57
Self-citationLee, J. G., Yon, J., Lin, C., Jung, A., Jung, K. Y., & Nam, S.-Y. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.08.040 · Cited by 57
Recent Patents in CNS Drug Discovery: The Management of Inflammation in the Central Nervous System
Nimmo, A., & Vink, R. (2009) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488909788452997 · Cited by 56
Neuroprotective role of intermittent fasting in senescence-accelerated mice P8 (SAMP8)
Tajes, M., Cuesta, J., Folch, J., Ortuño‐Sahagún, D., Verdaguer, E., Jiménez, A., Junyent, F., Lau, A., Camins, A., & Pallàs, M. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.04.010 · Cited by 52
Guida, N., Laudati, G., Anzilotti, S., Secondo, A., Montuori, P., Renzo, G. D., Canzoniero, L. M. T., & Formisano, L. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.08.010 · Cited by 51
Lu, C., Guo, Y., Li, J., Yao, M., Liao, Q., Xie, Z., & Li, X. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.09.105 · Cited by 51
Annabi, B., Lord-Dufour, S., Vézina, A., & Béliveau, R. (2012) · Drug Target Insights · doi:10.4137/dti.s9442 · Cited by 50
The effects of different familial Alzheimer’s disease mutations on APP processing in vivo
Þórðardóttir, S., Ståhlbom, A. K., Almkvist, O., Thonberg, H., Eriksdotter, M., Zetterberg, H., Blennow, K., & Graff, C. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0234-1 · Cited by 50
Chen, T., Ferruzzi, M. G., Wu, Q., Simon, J. E., Talcott, S. T., Wang, J., Ho, L., Todd, G., Cooper, B. R., Pasinetti, G. M., et al. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700111 · Cited by 49
Modulation of mitochondrial calcium as a pharmacological target for Alzheimer's disease
Hung, C. H.-L., Ho, J. Y. S., & Chang, R. C. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.05.003 · Cited by 47
Biophenols pharmacology against the amyloidogenic activity in Alzheimer’s disease
Omar, S. H. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.02.051 · Cited by 46
Resveratrol attenuates hypoxia-induced neurotoxicity through inhibiting microglial activation
Zhang, Q., Yuan, L., Zhang, Q., Gao, Y., Liu, G., Xiu, M., Wei, X., Wang, Z., & Liu, D. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.07.027 · Cited by 42
Kumar, R. K., Nigam, L., Singh, A. P., Singh, K. K., Subbarao, N., & Dey, S. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.11.001 · Cited by 41
Liu, Y., Chen, X., & Li, J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6304 · Cited by 39
Koz, S. T., Etem, E. Ö., Baydaş, G., Yüce, H., Ozercan, H. I., Kuloğlu, T., Köz, S., Etem, A., & Demir, N. (2012) · Brain Research · doi:10.1016/j.brainres.2012.09.026 · Cited by 36
Hu, W., Yang, E., Ye, J., Han, W., & Du, Z. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5527 · Cited by 36
Rupprich, N., & Kindl, H. (1978) · PubMed · Cited by 36
Huang, T., Gao, D., Jiang, X., Hu, S., Zhang, L., & Fei, Z. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2239 · Cited by 35
Chitarrini, G., Zulini, L., Masuero, D., & Vrhovšek, U. (2017) · PROTOPLASMA · doi:10.1007/s00709-017-1100-5 · Cited by 35
Resveratrol delays Wallerian degeneration in a NAD+ and DBC1 dependent manner
Calliari, A. J., Bobba, N., Escande, C., & Chini, E. N. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.11.013 · Cited by 30
Srikanta, A. H., Kumar, A., Sukhdeo, S. V., Peddha, M. S., & Govindaswamy, V. (2016) · Food & Function · doi:10.1039/c6fo00372a · Cited by 30
Hurtado-Gaitán, E., Sellés‐Marchart, S., Martínez‐Márquez, A., Samper-Herrero, A., & Bru‐Martínez, R. (2017) · Molecules · doi:10.3390/molecules22030418 · Cited by 27
Becker, L., Bellow, S., Carré, V., Latouche, G., Poutaraud, A., Merdinoglu, D., Brown, S., Cerović, Z. G., & Chaimbault, P. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b01002 · Cited by 27
Protective effect of resveratrol against nigrostriatal pathway injury in striatum via JNK pathway
Li, D., Liu, N., Zhao, L., Tong, L., Kawano, H., Yan, H., & Li, H.-P. (2016) · Brain Research · doi:10.1016/j.brainres.2016.10.013 · Cited by 26
In Vitro Glucuronidation and Sulfation of ε-Viniferin, a Resveratrol Dimer, in Humans and Rats
Courtois, A., Jourdes, M., Dupin, A., Lapèze, C., Renouf, E., Biais, B., Teissèdre, P., Mérillon, J., Richard, T., & Krisa, S. (2017) · Molecules · doi:10.3390/molecules22050733 · Cited by 25
Yin, H., Wang, H., Zhang, H., Gao, N., Zhang, T., & Yang, Z. R. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9726-9 · Cited by 23
Epidemiology of Alzheimer’s Disease
Xu, W., Ferrari, C., & Wang, H. (2013) · InTech eBooks · doi:10.5772/54398 · Cited by 22
Thomas, J., Garg, M. L., & Smith, D. W. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.03.002 · Cited by 20
Satoh, A., & Imai, S. (2014) · Aging · doi:10.18632/aging.100627 · Cited by 19
da Silva, L. F., Guerra, C. C., Klein, D., & Bergold, A. M. (2017) · Food Chemistry · doi:10.1016/j.foodchem.2017.01.087 · Cited by 14
Qiu, Z., Yu, J., Dai, Y., Yang, Y., Lu, X., Xu, J., Qin, Z., Huang, F., & Li, N. (2017) · Biomedical Chromatography · doi:10.1002/bmc.4001 · Cited by 14
Wine Chemical Composition and Radical Scavenging Activity of Some Cabernet Franc Clones
Popović‐Djordjević, J. B., Pejin, B., Dramićanin, A., Jović, S., Vujović, D., Zunic, D., & Ristić, R. (2017) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201018666170313100919 · Cited by 13
Neuroprotective effects of resveratrol: Potential mechanisms
Sahebkar, A. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.06.014 · Cited by 12
Neuronal activity and the expression of clathrin-assembly protein AP180
Wu, F., Mattson, M. P., & Yao, P. J. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.10.018 · Cited by 12
Stilbene Synthases and Stilbenecarboxylate Synthases, I
Rupprich, N., & Kindl, H. (1978) · Biological Chemistry · doi:10.1515/bchm.1978.359.1.165 · Cited by 12
Cited by
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638
Oxidative Stress and Antioxidants in Neurodegenerative Disorders
Olufunmilayo, E. O., Gerke-Duncan, M. B., & Holsinger, R. M. D. (2023) · Antioxidants · doi:10.3390/antiox12020517 · Cited by 670
“Other important antioxidant agents being evaluated as possible AD treatment options include ascorbyl palmitate [234], coenzyme Q [235], lipoic acid [236], resveratrol [237], silibinin [238] and gintonin [239].”
Chemical and Pharmacological Aspects of Caffeic Acid and Its Activity in Hepatocarcinoma
Espíndola, K. M. M., Ferreira, R. G., Narvaez, L. E. M., Silva Rosario, A. C. R., da Silva, A. H. M., Silva, A. G. B., Vieira, A. P. O., & Monteiro, M. C. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00541 · Cited by 610
Self-citationHippocampus and its involvement in Alzheimer’s disease: a review
Rao, Y. L., Ganaraja, B., Murlimanju, B. V., Joy, T., Krishnamurthy, A., & Agrawal, A. (2022) · 3 Biotech · doi:10.1007/s13205-022-03123-4 · Cited by 573
“Hence, SIRT1 regulates neuronal survival, insulin sensitivity, glucose metabolism, and mitochondrial biogenesis and thus maintains neuronal homeostasis (Gomes et al. 2018; Satoh and Imai 2014; Guarente 2013).”
BackgroundAstrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer’s disease
Singh, D. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02565-0 · Cited by 569
Metadata
- Authors
- Gomes, B. A. Q., Silva, J. P. B., Romeiro, C. F. R., dos Santos, S. M., Rodrigues, C. A., Gonçalves, P. R., Sakai, J. T., Mendes, P. F. S., Varela, E. L. P., & Monteiro, M. C.
- Affiliations
- Universidade Federal do Pará (BR)
- Corresponding author
- Monteiro, Marta Chagas
- ORCID
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2018-01
- Volume
- 2018
- Issue
- 1
- Pages
- 8152373-8152373
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- PMC
- PMC6232815
- OpenAlex
- W2898838755
- Cited by
- 403
- References
- 170
- Citations by year
- 2026: 40 · 2025: 52 · 2024: 52 · 2023: 58 · 2022: 58 · 2021: 54 · 2020: 64 · 2019: 24
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Oxidative Medicine and Cellular Longevity (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação Amazônia Paraense de Amparo à Pesquisa
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- resveratrol, Alzheimer's disease, SIRT1, neuroprotection, amyloid-beta aggregation, antioxidant activity, anti-inflammatory activity, microglial activation, M1 microglia, Th2 immune response, p53 deacetylation, neuronal apoptosis, neurogenesis, hippocampus
- MeSH terms
- Resveratrol, Alzheimer Disease, Animals, Antioxidants, Humans, Neuroprotective Agents, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.